Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00551070 · OUTCOME

Tumor Response

Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer · Source last updated 2020-12-03

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of patients
Interval / dispersion
90% Confidence Interval
Time frame
Every other cycle

What was measured

Complete and Partial Tumor Response by (Response Evaluation Criteria in Solid Tumors) RECIST 1.0

Analysis population: Eligible and treated patients

Groups in this outcome

AZD6244

AZD6244 (NSC #748727) 100 mg orally BID until disease progression or adverse effects prohibit further therapy (1 cycle =28 days)

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
AZD624452

Reported measurements

Source class 1
Values in percentage of patients · Interval/dispersion: 90% Confidence Interval
GroupValueSpreadLowerUpperComment
AZD624415.4Not reported7.926.1Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        7.9
        upper Limit
        26.1
        value
        15.4
denoms
  1. counts
    1. group Id
      OG000
      value
      52
    units
    Participants
description
Complete and Partial Tumor Response by (Response Evaluation Criteria in Solid Tumors) RECIST 1.0
dispersion Type
90% Confidence Interval
groups
  1. description
    AZD6244 (NSC #748727) 100 mg orally BID until disease progression or adverse effects prohibit further therapy (1 cycle =28 days)
    id
    OG000
    title
    AZD6244
param Type
NUMBER
population Description
Eligible and treated patients
reporting Status
POSTED
time Frame
Every other cycle
title
Tumor Response
type
PRIMARY
unit Of Measure
percentage of patients

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice